BFM
GILD icon

Boothbay Fund Management’s Gilead Sciences GILD Stock Holding History

Boothbay Fund Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$463K Buy
+3,321
New +$465K 0.01% 1395
2025
Q4 		– Sell
-2,220
Closed -$246K – 2099
2025
Q3 		$246K Buy
2,220
+241
+12% +$27.4K ﹤0.01% 1556
2025
Q2 		$219K Buy
+1,979
New +$211K ﹤0.01% 1212
2023
Q2 		– Sell
-146,807
Closed -$11.7M – 1984
2023
Q1 		$12.2M Buy
146,807
+75,972
+107% +$6.29M 0.25% 51
2022
Q4 		$6.08M Buy
+70,835
New +$5.61M 0.14% 163
2022
Q3 		– Sell
-4,983
Closed -$314K – 2363
2022
Q2 		$308K Buy
+4,983
New +$309K 0.01% 1447
2021
Q4 		– Sell
-6,190
Closed -$432K – 1985
2021
Q3 		$432K Sell
6,190
-97
-2% -$6.82K 0.01% 1151
2021
Q2 		$433K Sell
6,287
-8,162
-56% -$545K 0.01% 1081
2021
Q1 		$934K Buy
14,449
+6,674
+86% +$430K 0.04% 630
2020
Q4 		$453K Buy
+7,775
New +$469K 0.02% 791
2020
Q2 		– Sell
-12,900
Closed -$964K – 1020
2020
Q1 		$964K Buy
+12,900
New +$891K 0.08% 307
2018
Q1 		– Sell
-3,079
Closed -$221K – 752
2017
Q4 		$221K Buy
+3,079
New +$234K 0.03% 556
2017
Q3 		– Sell
-8,670
Closed -$663K – 659
2017
Q2 		$614K Buy
8,670
+1,733
+25% +$115K 0.13% 187
2017
Q1 		$471K Sell
6,937
-661
-9% -$46.5K 0.09% 274
2016
Q4 		$544 Sell
7,598
-1,130
-13% -$84K 0.12% 216
2016
Q3 		$691K Buy
8,728
+1,714
+24% +$139K 0.15% 143
2016
Q2 		$585K Buy
7,014
+2,943
+72% +$261K 0.23% 108
2016
Q1 		$374K Sell
4,071
-2,016
-33% -$182K 0.28% 117
2015
Q4 		$616K Buy
6,087
+2,220
+57% +$231K 0.27% 81
2015
Q3 		$380K Buy
3,867
+374
+11% +$41.5K 0.18% 122
2015
Q2 		$409K Buy
+3,493
New +$382K 0.16% 134

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Boothbay Fund Management's GILD Position: Q1 2026 in Review

Boothbay Fund Management opened a new position in Gilead Sciences (GILD) in Q1 2026: 3,321 shares worth $463K. The stake represents 0.01% of the portfolio and ranks #1395 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in GILD as recently as Q3 2025.

Boothbay Fund Management first reported a position in GILD in Q2 2015 and has held it in 21 quarters since. The position peaked at $12.2M in Q1 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Boothbay Fund Management held 3,321 shares of Gilead Sciences worth $463K as of Q1 2026.
  • Gilead Sciences was a new Boothbay Fund Management position in Q1 2026.
  • Gilead Sciences made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1395 holding.
  • Boothbay Fund Management first reported a position in Gilead Sciences in Q2 2015 and has held it in 21 quarters since.
  • Boothbay Fund Management's Gilead Sciences position peaked at $12.2M in Q1 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.